The
eMedical Dermatology Review Podcast December
2007: VOLUME
1, NUMBER 5
Community-Acquired
Methicillin-Resistant S. aureus (CA-MRSA) Skin And
Soft Tissue Infections
What
is a podcast?
A podcast is an audio recording posted online — much like a radio show
for your computer. It can be downloaded and listened to on your computer, iPod
or any other device that plays MP3's. It can also be streamed via the web — so
you can listen to it anywhere, at any time.
To learn more about podcasting and how to enjoy this exciting new
feature of eMedical Dermatology Review, click
here.
To
listen to the Podcast, follow the links below.
Click
to download the Edition here.
This saves the podcast directly on your computer's hard drive. There
you can manage and play it like any song or audio file by using your music
software (iTunes, Windows Media, Real Player, etc...) You can also transfer
it to your iPod or MP3 player to listen to it on-the-go.
You
can listen on the web here.
If you want to listen to the eMedical Dermatology Review Podcast right
away, just click on the above link and it will open an internet browser and
play the podcast for you via streaming media on the web.
Please note: This podcast is a large file, so please be patient as the
file downloads via the web. Once it's finished downloading,
it will take a few more minutes for the
toolbar to show. This could take a few minutes.
You
can subscribe to the eMedical Dermatology Review
Podcast here.
When you subscribe, you'll get new editions of the eMedical Dermatology
Review Podcast automatically downloaded to your hard drive as soon as it
becomes available. And just like the downloaded editions, you can manage
and play it like any song or audio file by using your music software (iTunes,
Windows Media, etc...) You can also transfer it to your iPod or MP3 player,
Real Player, etc. to listen to it on-the-go.
This
activity has been planned and implemented in accordance
with the Essential Areas and Policies of the Accreditation
Council for Continuing Medical Education through the joint
sponsorship of The Johns Hopkins University School of
Medicine, The Institute for Johns Hopkins Nursing, and
the University of Tennessee College of Pharmacy. The Johns
Hopkins University School of Medicine is accredited by
the ACCME to provide continuing medical education for
physicians.
The Institute for Johns Hopkins Nursing is accredited
as a provider of continuing nursing education by the American
Nurses Credentialing Center’s Commission on Accreditation.
Physicians
The Johns Hopkins University School of Medicine designates
this educational activity for a maximum of 0.5 AMA
PRA Category 1 Credit(s)TM. Physicians
should only claim credit commensurate with the extent
of their participation in the activity.
Nurses
This 0.5 contact hour Educational Activity (Provider Directed/Learner
Paced) is provided by The Institute for Johns Hopkins
Nursing. Each podcast carries a maximum of 0.5 contact
hours.
Pharmacists This
program is approved for 0.5 hour credit (0.05 CEUs) for
the podcast and is co-sponsored by the University of Tennessee
College of Pharmacy who is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing
pharmacy education. A statement of CE credit will be mailed
within 4 weeks of successful completion and evaluation
of the program. ACPE Program #064-999-07-256-L01-P.
Grievance Policy: A participant, sponsor,
faculty member or other individual wanting to file a grievance
with respect to any aspect of a program sponsored or co-sponsored
by the UTCOP may contact the Associate Dean for Continuing
Education in writing. The grievance will be reviewed and
a response will be returned within 45 days of receiving
the written statement. If not satisfied, an appeal to
the Dean of the College of Pharmacy can be made for a
second level of review.
This
activity has been developed for the Dermatologist, PharmD,
Nurses, Dermasurgeon, Dermatopathologist, Pediatric Dermatologist,
Immunodermatologist, Wound Care Specialist.
The
Offices of Continuing Education (CE) at The Johns Hopkins
University School of Medicine, The Institute for Johns
Hopkins Nursing and The University of Tennessee College
of Pharmacy are committed to protect the privacy of its
members and customers. The Johns Hopkins University maintains
its Internet site as an information resource and service
for physicians, other health professionals and the public.
The Johns Hopkins University School of Medicine, The Institute
for Johns Hopkins Nursing and The University of Tennessee
College of Pharmacy will keep your personal and credit
information confidential when you participate in a CE
Internet based program. Your information will never be
given to anyone outside The Johns Hopkins University and
The University of Tennessee College of Pharmacy program.
CE collects only the information necessary to provide
you with the service you request.
It
is the policy of The Johns Hopkins University School of
Medicine that the faculty and provider disclose real or
apparent conflict of interest relating to the topics of
this educational activity, and also disclose discussions
of unlabeled/unapproved uses of drugs or devices during
their presentation(s). Detailed disclosure will be made
in each newsletter.
Bernard
A. Cohen, MD has indicated a past and current
financial relationship with Novartis, Pharmaceuticals,
Astellas Pharma Inc., Medicis and Connetics. He
served on the Speaker's Bureau for Novartis, Pharmaceuticals,
Astellas Pharma Inc., and Medicis. He has also received
grants for studies from Novartis, Pharmaceuticals
and Astellas Pharma Inc. and received support for
a fellowship program from Connetics.
Susan
Matra Rabizadeh, MD, MBA has disclosed
no relationships with commercial supporters.
Mark
Lebwohl, MD has disclosed that he has received
grants for clinical research and educational activities
from, has served as an advisor, consultant and speaker
to, and has served as an investigator for Abbott,
Amgen, Astellas, Centecor, Genentech and Novartis.
Elizabeth
Sloand, PhD, CRNP, has disclosed no relationships
with commercial supporters.
The author has indicated that there will be references to unlabeled or unapproved uses of drugs or products in this presentation. Trimethoprim-sulfamethoxazole (TMP-SMX) is not FDA approved for treatment of any Staphylococcal infection.
The
opinions and recommendations expressed by faculty and
other experts whose input is included in this program
are their own. This enduring material is produced for
educational purposes only. Use of Johns Hopkins University
School of Medicine and The University of Tennessee College
of Pharmacy name implies review of educational format
design and approach. Please review the complete prescribing
information of specific drugs or combination of drugs,
including indications, contraindications, warnings and
adverse effects before administering pharmacologic therapy
to patients.